The EMA has recommended label expansions for Inaqovi, Opdivo, and Venclyxto, broadening treatment options in AML, Hodgkin lymphoma, and CLL.

Three clinically available drugs could pave the way for safer and more effective treatments for one of the most aggressive ...

Cancer cells can disarm the immune system not just by hiding from it, but by actively reprogramming nearby immune cells into a suppressed state. This previously unrecognized molecular interaction, ...

SAN DIEGO — Experimental therapies with radically different approaches are stirring a wave of optimism that survival rates ...

New findings of an Alliance Foundation Trials study show combining immunotherapy and chemotherapy before surgery improves ...

A newly published study reports that APC-deficient cancer cells may depend on a single metabolic enzyme for survival, revealing a potential strategy for selectively targeting tumours associated with ...

It’s a reasonable hope, given the results of that trial, which researchers presented at the American Association for Cancer ...

Popular artificial intelligence programs told users where to find alternative, potentially dangerous treatments for cancer ...

Neoadjuvant or perioperative immunotherapy, either alone or in combination with other antineoplastic agents (e.g., chemotherapy), has been shown to improve ...

(NEXSTAR) – An advance in vaccine technology is showing promise toward fighting the second-most common cause of death in the United States, cancer. Scientists are working on developing mRNA vaccines ...

Scientists have uncovered a hidden reason why cancer treatments don’t work equally well for everyone. Certain drugs can become trapped inside lysosomes within tumor cells, forming slow-release ...

The document was not newly declassified in 2026, nor does it reveal a suppressed cure for cancer. The report has been publicly available for years and simply summarizes a 1950 Soviet research paper, ...